Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced an update on its ongoing on-market buy-back program, indicating the purchase of 118,642 ordinary fully paid securities on the previous day, bringing the total number of securities bought back to 5,278,873. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science. The company provides digital cognitive assessment tools and services, primarily targeting clinical trials, academic research, and healthcare markets.
YTD Price Performance: 25.93%
Average Trading Volume: 10,929
Technical Sentiment Signal: Sell
Current Market Cap: $148.5M
For detailed information about CGS stock, go to TipRanks’ Stock Analysis page.